Patents by Inventor Sheila X. Zhou

Sheila X. Zhou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating diseases of the retina
    Patent number: 9561234
    Abstract: Disclosed herein is a method of treating disorders of the retina comprising administering to a patient in need of such treatment a compound selected from the group consisting of olanzapine, certain of its metabolites, clozapine, and n-desmethyl clozapine.
    Type: Grant
    Filed: April 27, 2015
    Date of Patent: February 7, 2017
    Assignee: Allergan, Inc.
    Inventors: Jyotirmoy Kusari, Sheila X. Zhou, Mingting Tian, Edwin U. Padillo, Sandhya S. Rao, Daniel W. Gil, Larry A. Wheeler
  • METHODS FOR TREATING DISEASES OF THE RETINA
    Publication number: 20150290215
    Abstract: Disclosed herein is a method of treating disorders of the retina comprising administering to a patient in need of such treatment a compound selected from the group consisting of olanzapine, certain of its metabolites, clozapine, and n-desmethyl clozapine.
    Type: Application
    Filed: April 27, 2015
    Publication date: October 15, 2015
    Inventors: Jyotirmoy Kusari, Sheila X. Zhou, Mingting Tian, Edwin U. Padillo, Sandhya S. Rao, Daniel W. Gil, Larry A. Wheeler
  • Methods for treating diseases of the retina
    Patent number: 9018202
    Abstract: Disclosed herein is a method of treating disorders of the retina comprising administering to a patient in need of such treatment a compound selected from the group consisting of olanzapine, certain of its metabolites, clozapine, and n-desmethyl clozapine.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: April 28, 2015
    Assignee: Allergan, Inc.
    Inventors: Jyotirmoy Kusari, Sheila X. Zhou, Mingting Tian, Edwin U. Padillo, Sandhya S. Rao, Daniel W. Gil, Larry A. Wheeler
  • Methods for Treating Diseases of the Retina
    Publication number: 20120142675
    Abstract: Disclosed herein is a method of treating disorders of the retina comprising administering to a patient in need of such treatment a compound selected from the group consisting of olanzapine, certain of its metabolites, clozapine, and n-desmethyl clozapine.
    Type: Application
    Filed: November 16, 2011
    Publication date: June 7, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Jyotirmoy Kusari, Sheila X. Zhou, Mingting Tian, Edwin U. Padillo, Sandhya S. Rao, Daniel W. Gil, Larry A. Wheeler
  • Stable RXR expressing cell line
    Publication number: 20030228632
    Abstract: Stable cell lines which express retinoid receptors and the insulin receptor are prepared and are useful in identifying agonists and antagonists of retinoid receptors. Agonists and antagonists of the RXR receptor can be determined using the cell lines of the invention which are producers of RXR alone; agonists and antagonists of other retinoid receptors can be determined using cell lines transfected with RXR and the desired retinoid receptor.
    Type: Application
    Filed: May 8, 2001
    Publication date: December 11, 2003
    Applicant: Allergan Sales, Inc.
    Inventors: Jyotirmoy Kusari, Sheila X. Zhou, Hongzhi Liu, Ramilla O. Lewis, Roshantha A. Chandraratna